Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gustaf Ortsäter

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersSophie Roth, Gustaf Ortsäter, Joana Amorim Freire
Advances in Therapy|October 19, 2019
A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT<sup>®</sup> Re-usable in the Nordics and BeneluxGustaf Ortsäter, Fredrik Borgström, Stéphane Soulard, et al.
Applied Health Economics and Health Policy|December 7, 2019
Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT<sup>®</sup> Re-usable InhalerGustaf Ortsäter, Fredrik Borgström, Mike Baldwin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 9, 2020
History of Previous Fracture and Imminent Fracture Risk in Swedish Women Aged 55 to 90 Years Presenting With a Fragility FractureEmese Toth, Jonas Banefelt, Kristina Åkesson, et al.
Journal of Neuromuscular Diseases|July 4, 2026
Disease progression and economic burden of duchenne muscular dystrophy: A retrospective study using Swedish register dataThomas Sejersen, Anna-Karin Kroksmark, Aina Törnblom, et al.
BMC Infectious Diseases|December 4, 2019
Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategiesChristian Krauth, Siegbert Rossol, Gustaf Ortsäter, et al.
Calcified Tissue International|March 27, 2016
Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX(®) in PortugalAndréa Marques, Óscar Lourenço, Gustaf Ortsäter, et al.
Archives of Osteoporosis|April 10, 2019
Differing impact of clinical factors on the risk of fracture in younger and older women in the general population and an osteoporosis clinic populationRosa Lauppe, Kristina E Åkesson, Östen Ljunggren, et al.
European Journal of Clinical Pharmacology|February 10, 2026
Dynamics of long-term adherence to lipid-lowering therapy in patients after myocardial infarctionEmil Hagström, Gustaf Ortsäter, Emil Almlöf, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 29, 2021
Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate-Treated Patients in a Real-World SettingJonas Banefelt, Jen Timoshanko, Emma Söreskog, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersSophie Roth, Gustaf Ortsäter, Joana Amorim Freire
Advances in Therapy|October 19, 2019
A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT<sup>®</sup> Re-usable in the Nordics and BeneluxGustaf Ortsäter, Fredrik Borgström, Stéphane Soulard, et al.
Applied Health Economics and Health Policy|December 7, 2019
Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT<sup>®</sup> Re-usable InhalerGustaf Ortsäter, Fredrik Borgström, Mike Baldwin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 9, 2020
History of Previous Fracture and Imminent Fracture Risk in Swedish Women Aged 55 to 90 Years Presenting With a Fragility FractureEmese Toth, Jonas Banefelt, Kristina Åkesson, et al.
Journal of Neuromuscular Diseases|July 4, 2026
Disease progression and economic burden of duchenne muscular dystrophy: A retrospective study using Swedish register dataThomas Sejersen, Anna-Karin Kroksmark, Aina Törnblom, et al.
BMC Infectious Diseases|December 4, 2019
Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategiesChristian Krauth, Siegbert Rossol, Gustaf Ortsäter, et al.
Calcified Tissue International|March 27, 2016
Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX(®) in PortugalAndréa Marques, Óscar Lourenço, Gustaf Ortsäter, et al.
Archives of Osteoporosis|April 10, 2019
Differing impact of clinical factors on the risk of fracture in younger and older women in the general population and an osteoporosis clinic populationRosa Lauppe, Kristina E Åkesson, Östen Ljunggren, et al.
European Journal of Clinical Pharmacology|February 10, 2026
Dynamics of long-term adherence to lipid-lowering therapy in patients after myocardial infarctionEmil Hagström, Gustaf Ortsäter, Emil Almlöf, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 29, 2021
Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate-Treated Patients in a Real-World SettingJonas Banefelt, Jen Timoshanko, Emma Söreskog, et al.
Pageof 2